SNOA · Sonoma Pharmaceuticals Inc
United States · RS rating 36 · As of 2026-11-03
| Price | 1.14 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 42 / 69 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 8 / 29 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -50.0% |
| Sales growth Q/Q | -22.4% |
| Distance from 52-week high | +70.0% |
| Market cap (USD) | $3.1M |